SAFE vs Convertible Note: What Founders Sign

The Short Answer Founders Skip Over

Nine out of ten pre-seed rounds are now closed on SAFEs. A decade of founders learning, sometimes the hard way, that convertible notes carry baggage that shows up at the worst possible moment.

Convertible notes are the right tool in specific situations. Getting this choice wrong costs you equity, control, or both.

This is the breakdown you need before you sign anything.

What a SAFE Is

SAFE stands for Simple Agreement for Future Equity. Y Combinator created it and released the first version in 2013. The idea was simple: strip a convertible note down to its core and remove the parts that hurt founders most.

A SAFE is an agreement where you take money from an investor today, and they get equity later when you raise a priced round.

The conversion happens automatically when you close a preferred stock financing round. The investor gets shares based on a valuation cap, a discount, or both.

That is the entire structure. One document. One negotiation point in most cases. Done.

Because a SAFE is not a debt instrument, it does not appear on your balance sheet as a liability. It sits in an accounting gray zone as a warrant for future equity. Institutional investors will review your books before a Series A.

What a Convertible Note Is

A convertible note is a loan. It is structured as short-term debt that converts into equity when a triggering event occurs, typically your next priced round.

Every convertible note has four core terms.

Interest rate. Convertible notes typically accrue interest at four to eight percent annually, with seven percent as the median. That interest accrues whether you are growing or struggling. When the note converts, the accrued interest converts too, which means you are not just diluting on the principal. On a $500,000 note at five percent interest over 24 months, founders accrue $50,000 in additional principal that also converts to equity. That is roughly ten percent more dilution beyond the original amount.

Maturity date. Convertible notes typically mature in 18 to 36 months. If you have not raised a priced round by then, the investor can demand repayment or renegotiate. In practice, investors almost always agree to extend rather than demand cash back. But you are negotiating from a position of weakness. The investor holds the power and knows it.

Valuation cap. The cap sets the maximum valuation at which the investor money converts to equity. If your Series A prices at $10 million but your note has a $5 million cap, the investor converts as if your company were worth $5 million. They get twice as many shares as an investor coming in at the Series A price.

Discount rate. In my experience, convertible notes include a percentage discount on the share price paid by new investors. A 20 percent discount means a note holder converts at $0.80 per share when new investors pay $1.00. When both a cap and a discount exist, the investor gets whichever gives them the better price per share. A low cap combined with a strong discount can create a very investor-friendly outcome for the note holder and a heavily dilutive one for the founder.

The Numbers Side by Side

Here is what the key terms look like in practice across both instruments.

Why SAFEs Won the Pre-Seed Market

SAFEs now comprise a record high of 90 percent of all pre-seed rounds tracked on Carta. That is the highest figure ever recorded on the platform.

Speed is the biggest driver. A SAFE is typically a one-to-five page document. You can close with an investor the moment both parties sign and money wires. There is no coordinating multiple parties, no negotiating over interest rates, no calendar pressure from maturity provisions.

For founders, that speed matters more than it sounds. Every week your round stays open is a week you are distracted from building. Every legal revision adds cost and extends the close. SAFEs cut through that.

Simplicity also reduces the back-and-forth at the negotiation table. With a post-money SAFE, founders and investors typically only negotiate one term: the valuation cap. That single-item negotiation is why YC built the instrument this way from the beginning.

There is also a compounding network effect. About 90 percent of seed-stage deals at accelerators are structured as SAFEs. I see this consistently - founders in the same peer group raise on SAFEs, and the investors around them are already comfortable with the format. Using a convertible note when investors expect a SAFE creates unnecessary friction before you have even started talking about your business.

The Post-Money SAFE Problem Founders Miss

I stopped reading most articles here. They say SAFEs are great and move on. But the switch from pre-money to post-money SAFEs created a dilution dynamic that still catches founders off guard.

With a post-money SAFE, each investor ownership percentage is fixed relative to the company post-money valuation. New SAFE investors only dilute the founders, not each other. With a pre-money SAFE, all SAFE investors dilute each other as well as the founders, spreading the dilution around.

Here is what that looks like in practice. Say three investors each put in $1 million on a $10 million post-money valuation cap. Each investor locks in exactly 10 percent of the company. The founder is diluted 30 percent total.

Run the same scenario with pre-money SAFEs at a $9 million pre-money cap. The total raise is $3 million, creating a $12 million post-money. Each investor ends up at roughly 8.3 percent. The founder gives away around 25 percent, not 30.

That five percent difference at an early stage can translate to millions of dollars at exit. Post-money SAFEs now represent 85 percent of the SAFE market, so founders need to model dilution before signing, not after.

A higher valuation cap with a smaller raise softens the post-money structure. A lower cap with a larger raise makes it expensive fast.

When a Convertible Note Makes Sense

There are three situations where a convertible note beats a SAFE. The pattern is consistent across early-stage financing.

Bridge rounds between priced financings. If you have already done a Series A and need $500K to $2 million to extend runway to your Series B, a convertible note with a defined maturity date signals commitment to closing the next round on a set timeline. You have already priced the company once, so the maturity date functions as accountability rather than threat. The structured timeline also creates useful urgency for investors sitting on the fence.

Institutional investors who require debt terms. Some corporate strategic investors and family offices have internal policies that require debt instruments. They cannot invest via a SAFE regardless of how clean the terms are. In those cases, the choice is made for you. You use a convertible note or you walk away from the check.

Near-term priced rounds. If you are three months from closing a Series A and need $300,000 to extend to that close, a short-term convertible note with a maturity date aligned to your expected Series A close makes the temporary nature explicit for both sides. When both parties know the conversion is imminent, the maturity pressure is more feature than bug.

What convertible notes are not good for: raising from angel investors who expect simplicity, closing rounds that drag on for months, or situations where your next priced round is speculative rather than imminent.

The Maturity Date Is Not Just an Expiration Date

This is the part of the convertible note that founders underestimate. The maturity date gives the investor leverage.

When a convertible note matures without conversion, investors can demand repayment, force a conversion at unfavorable terms, or agree to extend - but only in exchange for better terms. Every one of those options favors the investor.

In practice, investors almost always agree to extend because demanding cash repayment from a struggling startup is bad optics and destroys the relationship. But multiple extensions signal to the broader market that your fundraising is not going well. That signal has consequences beyond the note itself.

Practitioners who negotiate these deals recommend pushing for a 24-month maturity at minimum, not 12 to 18 months, and including an automatic conversion to equity at maturity at a specified valuation if no priced round occurs. That provision protects founders from the repayment cliff without requiring investor goodwill to kick in at the worst moment.

The Conversion Trigger Difference That Changes Everything

The conversion trigger works differently in each instrument.

A SAFE typically converts in any priced preferred stock round, regardless of how much money you raise. If a Series A investor puts in $200,000, the SAFE converts. There is no minimum.

A convertible note typically has a qualified financing threshold. The note might specify it only converts when you raise at least $1 million in a priced equity round. If you close a smaller bridge, the note may not convert. It just continues to sit there, accruing interest, approaching its maturity date.

That difference matters a lot if your path to a priced round is uncertain or nonlinear. With a SAFE, any priced equity event triggers conversion and cleans up your cap table. With a convertible note, you could go through several smaller rounds before the note converts, while interest accumulates the entire time.

Tax Treatment and Your Balance Sheet

I have watched founders burn weeks untangling tax issues that could have been avoided with one conversation before the round closed. They should.

SAFEs create zero tax paperwork until conversion. The IRS treats them as variable prepaid forward contracts with no tax consequences and no annual reporting requirements. That is a clean structure for early-stage operations where administrative overhead is already high relative to the team size.

Convertible notes are debt instruments. Recording a liability on your balance sheet is the real cost of that interest deduction. Some institutional investors checking your financials before a Series A will flag that liability in due diligence. For most pre-seed rounds, that is not a deal-breaker, but it adds a conversation you would not otherwise have.

For investors, interest on a convertible note is taxed as ordinary income when received, not as capital gains. For SAFE investors, there are no tax consequences until conversion. These differences shape investor preferences in ways that are not always stated explicitly in negotiations.

Stacking Multiple SAFEs and Why It Gets Complicated

Many founders run rolling SAFE rounds, closing individual checks as investors commit rather than waiting for a fixed close date. That flexibility is one of the SAFE best features.

But stacking multiple post-money SAFEs creates a compounding dilution effect that is easy to miss without modeling. Each new post-money SAFE locks in a fixed ownership percentage for that investor. Every subsequent SAFE hits the founders and existing shareholders, not the prior SAFE holders.

In theory, it is possible to sell enough post-money SAFEs to wipe out the founders entirely. That has happened in documented cases with very low valuation caps and large aggregate raises. It happens.

The practical takeaway: model your cap table before each SAFE, not after. Run a pro forma that shows what happens at Series A conversion under different scenarios. If you are raising multiple tranches, set a total raise target before you start, not as you go. Without careful modeling, founders lose sight of how much future equity has already been promised before a single share is issued.

What Investors Think About Each Instrument

Investor preference has shifted dramatically toward SAFEs, but it is not universal.

Angel investors and former founders who have raised on SAFEs themselves almost always prefer SAFEs when they become investors. The instrument is familiar, fast, and requires minimal back-and-forth. Early-stage funds at the pre-seed level work the same way from what I've seen - they want to move fast and SAFEs let them do that.

Traditional institutional investors, family offices, and some international investors still prefer convertible notes. The reasons are structural. Convertible notes give them creditor rights. If the company is liquidated before conversion, noteholders are repaid before common shareholders. SAFE holders rank after noteholders in a liquidation. That priority difference is not academic for investors who write larger checks across many companies.

There is also a regulatory dimension for international raises. SAFEs are generally accepted in the US but can face scrutiny in other jurisdictions. If you are raising from investors in Europe, Asia, or Latin America, confirm that your legal structure is valid in their jurisdiction before using a standard YC SAFE template. Some international angels are unfamiliar with the instrument and will default to requesting a convertible note simply because it maps to a legal category they recognize.

Legal Costs and Closing Speed

Legal costs on SAFEs typically stay under $2,000 per transaction.

Standard SAFE templates require minimal customization. Legal costs typically run up to $2,000 per transaction. The YC templates are available for free and are widely used without modification. You can close a SAFE with a founder-friendly law firm in a matter of days.

Convertible notes require more documentation covering interest calculations, maturity provisions, and default scenarios. Legal costs often run $2,000 to $5,000 per transaction. If investors want to negotiate unusual provisions, those costs climb further.

Investors pushing to negotiate your SAFE closes the cost gap. Despite the template advisory note against changes, it gets modified regularly in practice. Every modification requires legal review on both sides.

The practical speed advantage for SAFEs is two to four weeks over convertible notes for comparable rounds. That time difference compounds when you are running multiple parallel closes in a rolling SAFE round.

Which One to Use and When

When I talk to early-stage founders about this, the answer is almost always the same: use a post-money SAFE unless your investors specifically require something else.

Use a SAFE if you are raising pre-seed or early seed from angels, former founders, or accelerators. Use a SAFE if you want to close fast and model your dilution with one variable. Your next priced round being speculative rather than imminent is also a reason to go this route.

Use a convertible note if you are doing a bridge round between priced financings and want the timeline pressure to be explicit. Use a convertible note if institutional investors require debt terms as a matter of policy. If your Series A close is genuinely imminent and you want the instrument structure to reflect that, a convertible note fits better.

There is one situation that trips up founders more than any other: using a SAFE for what is effectively a bridge round late in the company life. At that stage, the lack of maturity pressure means the investor has no structural urgency to support your next round. The SAFE sits on your cap table indefinitely. That indefinite status can complicate future fundraising conversations if new investors ask why prior capital has not converted.

Match the instrument to the stage and the situation. Do not default to whichever one sounds simpler without modeling the dilution first.

Before You Sign: The Questions Worth Asking

Whichever instrument you choose, the terms inside it matter as much as the instrument itself. A SAFE with a very low valuation cap can dilute you more than a convertible note with a fair cap and a reasonable interest rate.

What is the valuation cap relative to what a reasonable Series A investor would pay? If your cap is $3 million and you think your Series A will price at $15 million, that early investor is getting shares at one-fifth the price. Run that math before you commit.

Is there both a cap and a discount? YC specifically recommends using one or the other, not both. Their updated SAFE templates no longer include a combined cap-and-discount version. When both exist, the investor always gets the better of the two outcomes. That is explicitly compounding protection for the investor at the founder expense.

What triggers conversion? For notes, what is the minimum qualified financing threshold? Could you close a small bridge round and leave the note outstanding while it continues accruing interest?

If using a convertible note, what happens at maturity if you have not raised? Is there automatic conversion language, or does it default to a repayment obligation?

If using multiple SAFEs, what does your cap table look like at Series A conversion under a realistic valuation? Build a pro forma before each close, not after the round is finished.

If you want to work through your specific situation with someone who has been on both sides of these deals, Learn about Galadon Gold - direct coaching from operators who have built and sold businesses and have lived through exactly these decisions.

What the Adoption Data Shows

The numbers tell a clear story. Among startups raising less than $1 million, 85 percent choose SAFEs over priced equity rounds. Women-led startups use SAFEs 10 percent more frequently than male-led ones. In my experience watching first-time founders navigate their first raise, the pull toward SAFEs is overwhelming - I'd put it at roughly 76 percent choosing them over priced equity rounds.

The pattern holds at accelerators too. Roughly 90 percent of seed-stage deals at accelerators are structured as SAFEs. For startups in those programs, roughly half secure their first external funding through SAFEs.

Convertible notes have seen a modest resurgence, making up roughly 32 percent of convertible instruments in recent quarters. That uptick reflects institutional investors pushing for more structured terms in a tighter funding environment. Interest rates on convertible notes with valuation caps climbed to an average of 8 percent in that period, compared to 6 percent the prior period, reflecting broader economic pressure on early-stage terms.

SAFEs dominate pre-seed and seed because they match the operational reality of early-stage companies. Convertible notes remain relevant because they match the legal and structural preferences of a specific subset of investors.

Know which investor you are talking to before you propose an instrument. Run the dilution math before you are in the room.